Sullivan RJ - Search Results

1

Resistance to BRAF-targeted therapy in melanoma.

Sullivan RJ, Flaherty KT. Sullivan RJ, et al. Eur J Cancer. 2013 Apr;49(6):1297-304. doi: 10.1016/j.ejca.2012.11.019. Epub 2013 Jan 2. Eur J Cancer. 2013. PMID: 23290787 Review.

2

Molecular-targeted therapy in malignant melanoma.

Sullivan RJ, Atkins MB. Sullivan RJ, et al. Expert Rev Anticancer Ther. 2009 May;9(5):567-81. doi: 10.1586/era.09.20. Expert Rev Anticancer Ther. 2009. PMID: 19445574 Review.

3

Targeted therapy for Kaposi sarcoma.

Sullivan RJ, Pantanowitz L, Dezube BJ. Sullivan RJ, et al. BioDrugs. 2009;23(2):69-75. doi: 10.2165/00063030-200923020-00001. BioDrugs. 2009. PMID: 19489649 Free PMC article. Review.

4

Cytokine therapy in melanoma.

Sullivan RJ, Atkins MB. Sullivan RJ, et al. J Cutan Pathol. 2010 Apr;37 Suppl 1:60-7. doi: 10.1111/j.1600-0560.2010.01507.x. J Cutan Pathol. 2010. PMID: 20482677 Review. No abstract available.

5

An inexpensive, specific and highly sensitive protocol to detect the BrafV600E mutation in melanoma tumor biopsies and blood.

Panka DJ, Sullivan RJ, Mier JW. Panka DJ, et al. Among authors: sullivan rj. Melanoma Res. 2010 Oct;20(5):401-7. doi: 10.1097/CMR.0b013e32833d8d48. Melanoma Res. 2010. PMID: 20679909 Free PMC article.

6

Molecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyond.

Sullivan RJ, Atkins MB. Sullivan RJ, et al. Expert Opin Investig Drugs. 2010 Oct;19(10):1205-16. doi: 10.1517/13543784.2010.504709. Expert Opin Investig Drugs. 2010. PMID: 20687784 Review.

7

Impact of concomitant immunosuppression on the presentation and prognosis of patients with melanoma.

Frankenthaler A, Sullivan RJ, Wang W, Renzi S, Seery V, Lee MY, Atkins MB. Frankenthaler A, et al. Among authors: sullivan rj. Melanoma Res. 2010 Dec;20(6):496-500. doi: 10.1097/CMR.0b013e32833e9f5b. Melanoma Res. 2010. PMID: 20823779

8

Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanoma.

DeRose ER, Pleet A, Wang W, Seery VJ, Lee MY, Renzi S, Sullivan RJ, Atkins MB. DeRose ER, et al. Among authors: sullivan rj. Melanoma Res. 2011 Aug;21(4):364-9. doi: 10.1097/CMR.0b013e3283471086. Melanoma Res. 2011. PMID: 21540750 Free PMC article.

9

Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma.

Joseph RW, Sullivan RJ, Harrell R, Stemke-Hale K, Panka D, Manoukian G, Percy A, Bassett RL, Ng CS, Radvanyi L, Hwu P, Atkins MB, Davies MA. Joseph RW, et al. Among authors: sullivan rj. J Immunother. 2012 Jan;35(1):66-72. doi: 10.1097/CJI.0b013e3182372636. J Immunother. 2012. PMID: 22130161 Free PMC article.

10

BRAF in Melanoma: Pathogenesis, Diagnosis, Inhibition, and Resistance.

Sullivan RJ, Flaherty KT. Sullivan RJ, et al. J Skin Cancer. 2011;2011:423239. doi: 10.1155/2011/423239. Epub 2011 Nov 17. J Skin Cancer. 2011. PMID: 22175026 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results